Cancer

At the Kolling Institute, our cancer research aims to identify and overcome the factors that drive cancer development so that we can improve patient outcomes. We have a number of cancer research teams with different expertise, specialising in chemotherapy resistance, immunotherapies, genetics, epigenetics, diagnostic services and clinical trials. Importantly, these teams have access to an active tissue bank and the latest equipment.

Our cancer research rapidly implements laboratory findings into clinical practice and is supported by the Cancer Institute Translational Centre, Sydney Vital. By bringing together research scientists, clinicians and allied health professionals, we are able to combine innovative and cutting edge research with personalised treatment strategies for cancer patients.

Find out more about:

Bill Walsh Translational Cancer Research Laboratory

Bowel Cancer and Biomarker Research Lab

Breast Cancer Research

Cancer Genetics Laboratory

Kolling Institute Tumour Bank

Events, News and Seminars

Kolling Research Symposium 2024

Kolling Research Symposium 2024

We would like to thank everyone involved in the 2024 Kolling Institute Symposium. During the event, ..... Read more

Category: Cardiovascular and Renal Research, Musculoskeletal Research, Neuroscience and Pain Research, Presentations, Research Excellence

Kolling NEWS

Kolling NEWS

Our Kolling Institute newsletter brings together a collection of profiles on our impressive research..... Read more

Category: New Treatment, Newsletters, Research Excellence

Spotlight on clinical trials

Spotlight on clinical trials

Kolling Institute researcher and Royal North Shore Hospital endocrinologist Professor Rory Clifton-B..... Read more

Category: New Treatment, Research Excellence